ASENT 2026 Annual Meeting & Clinical Trials Course

The ASENT 2026 Annual Meeting and Clinical Trials Course is the premier scientific and networking event in neurotherapeutic drug and device development and discovery. This year, the meeting will return to the Hyatt Regency Bethesda, in Bethesda, MD from March 2-6, 2026.

Neurotherapeutic Clinical Trials Course: March 2-3
ASENT 2026 Annual Meeting: March 4-6

This neurotherapeutic drug and device development and discovery conference is where leaders from providers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers in the neurology and neuroscience space gather to discuss: “how can we improve the process of bringing neurotherapeutics to market?”

The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, tabletop exhibits, networking meetings, pipeline presentations and poster sessions.

Topic Areas

• Advancing Cell Therapies for Neurological Autoimmunity
• GLP-1 as a therapeutic target in neurological disorders
• Implications of early AD detection and diagnosis: Breakthrough for prevention and experimental therapeutic intervention?
• The Future of Blood Biomarkers in Neurodegenerative Disease Diagnosis and Drug Development
• ASENT–JSNT Joint Symposium: International collaboration (US-Japan) to develop neurotherapeutics: opportunities and challenges
• Incorporating novel outcome assessments in early phase trials
• Precision Medicine Advances in Adult and Pediatric Gliomas
• Focused Ultrasound Potential in Neurological Conditions
• Rejuvenating and Re-Investing in Stroke Therapeutics
• Neuromodulation for neurodegenerative and psychiatric disease.
  Visit ASENT.org/AnnualMeeting2026 to REGISTER

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher ASENT